APA   Click to copy
Nardi, F., Perurena, N., Schade, A. E., L, Z.-H., Ngo, K., Ivanova, E. V., … Cichowski, K. (2023). Co-targeting a MYC-eIF4A survival axis improves the efficacy of KRAS inhibitors in lung cancer. Journal of Clinical Investigation. https://doi.org/10.1172/JCI167651

Chicago/Turabian   Click to copy
Nardi, Francesca, Naiara Perurena, Amy E. Schade, Ze-Hua L, Kenneth Ngo, Elena V. Ivanova, Aisha Saldanha, et al. “Co-Targeting a MYC-eIF4A Survival Axis Improves the Efficacy of KRAS Inhibitors in Lung Cancer.” Journal of Clinical Investigation (2023).

MLA   Click to copy
Nardi, Francesca, et al. “Co-Targeting a MYC-eIF4A Survival Axis Improves the Efficacy of KRAS Inhibitors in Lung Cancer.” Journal of Clinical Investigation, 2023, doi:10.1172/JCI167651.

@article{francesca2023a,
  title = {Co-targeting a MYC-eIF4A survival axis improves the efficacy of KRAS inhibitors in lung cancer},
  year = {2023},
  journal = {Journal of Clinical Investigation},
  doi = {10.1172/JCI167651},
  author = {Nardi, Francesca and Perurena, Naiara and Schade, Amy E. and L, Ze-Hua and Ngo, Kenneth and Ivanova, Elena V. and Saldanha, Aisha and Li, Chendi and Gokhale, Prafulla C. and Hata, Aaron N. and Barbie, David A. and Paweletz, Cloud P. and Janne, Pasi A. and Cichowski, Karen}
}